0001062993-11-002022.txt : 20110511
0001062993-11-002022.hdr.sgml : 20110511
20110511123050
ACCESSION NUMBER: 0001062993-11-002022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110509
FILED AS OF DATE: 20110511
DATE AS OF CHANGE: 20110511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gitman Paul
CENTRAL INDEX KEY: 0001375378
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34236
FILM NUMBER: 11831016
MAIL ADDRESS:
STREET 1: 167 EXECUTIVE DRIVE
CITY: MANHASSET HILLS
STATE: NY
ZIP: 11040
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP
CENTRAL INDEX KEY: 0000875622
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113054851
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 WILBUR ST
CITY: LYNBROOK
STATE: NY
ZIP: 11563
BUSINESS PHONE: 5165937000
MAIL ADDRESS:
STREET 1: 35 WILBUR STREET
CITY: LYNBROOK
STATE: NY
ZIP: 11563
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0303
4
2011-05-09
0000875622
BIOSPECIFICS TECHNOLOGIES CORP
BSTC
0001375378
Gitman Paul
167 EXECUTIVE DRIVE
MANHASSET HILLS
NY
11040
1
0
0
0
Common Stock, $0.001 par value
2011-05-09
4
M
0
15000
0.83
A
56425
D
Stock Option (Right to Buy)
0.83
2011-05-09
4
M
0
15000
0.00
D
2016-09-05
Common Stock, $0.001 par value
15000
0
D
The option became exercisable in twelve equal monthly installments beginning on October 6, 2006.
/s/ Paul Gitman by Carl A. Valenstein, attorney in fact
2011-05-11